Verified ComparisonLast updated: 8 April 2026
FOX04-DRI vs Epitalon
FOX04-DRI (forkhead-box O4 dominant-repressor inhibitor) removes senescent cells. Epitalon extends telomeres. Different cellular aging mechanisms.
FOXO4-DRI
Longevity
4.1/ 5
A−
Epitalon
Longevity
3.7/ 5
B
Editor's note
FOX04-DRI targets senescent cells; Epitalon activates telomerase. Complementary aging pathways.
| Criterion | FOXO4-DRI | Epitalon |
|---|---|---|
| Mechanism | Senescent-cell clearance | Telomerase activation |
| Cellular target | Senescent cells | Telomere length |
| Preclinical evidence | Growing | Established |
| In vivo rejuvenation data | Promising (mouse models) | Limited human data |
| Synergistic potential | Yes (with telomerase activators) | Yes (with senolytic agents) |
Frequently asked questions
FOX04-DRI has promising mouse senescence data; Epitalon has longer preclinical history but less recent momentum.
Want to read the full reviews?